Aller au contenu

ARNA Seminar Series - Dr. Béatrice Gerland (Equipe MoNA LISA, LSPCMIB, Université de Toulouse)

Béatrice Gerland (Equipe MoNA LISA, LSPCMIB, Université de Toulouse) est l'invitée de Valérie Desvergnes lors du prochain séminaire du laboratoire ARNA qui se tiendra le 20 mai à 10h au BBS.

BBS, Amphithéâtre, campus Carreire

Béatrice Gerland présentera sa conférence intitulée "Structuration and Functionalisation of oligonucleotides for biomimetic applications"

Abstract

To modulate the biological or biotechnical properties of oligonucleotides (ON), the group has focused on the introduction of modifications at the under- exploited 5'-position of nucleosides. First, the 5'-carbon was connected in astereo-controlled manner to the phosphate moiety of the nucleotide chain. The resulting conformationally constrained nucleotides bear a 1,3,2,- dioxaphosphorinane ring within the sugar-phosphate backbone, locking the conformation of torsional angles either into canonical or non-canonical values, leading to the enhanced stabilization of the targeted DNA secondary structures. Meanwhile, the synthetic development of 5'-C-propargyl nucleotides led, after SPS, to convertible ON (CvON). Their post synthetic conjugation by CuAAC reaction gave access to functionalized oligonucleotides (FuON) modified to expand their catalytic repertoire towards biomimetic reactions. In the challenging field of protease-like DNA catalysts, those nucleic mimics were designed to ultimately be able to perform the hydrolysis of the amide bond. Inspired by the serine proteases relying on a catalytic triad of three cooperative amino acids, serine, histidine and aspartate, the azide molecules bearing the corresponding side chain-like residues (carboxylate, imidazole and aspartate), alongside a synthetic organocatalyst presenting the three required groups, were conjugated onto CvON. Then, by taking advantage of the controlled folding of DNA, the resulting FuON were assembled into different secondary structures with the goal of reproducing the active site of the serine proteases. The results and perspectives of this approach will be then presented.

Contact

  • Valérie Desvergnes

Flyer Conférence Dr. Béatrice Gerland

Dernière mise à jour :

Télécharger (PDF - 322,06 KB)